[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353007-105":59,"doc-detail-353007-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cytokine-induced-killer-cik-cells-associated-transcriptome-signature-reveals-the-potential-immunomodulatory-role-of-tnfsf14-in-clear-cell-renal-cell-carcinoma","Cytokine-induced killer (CIK) Cells-associated transcriptome signature reveals the potential immunomodulatory role of TNFSF14 in clear cell renal cell carcinoma","","Among adoptive immune cell therapies, cytokine-induced killer (CIK) cell therapy shows clear relevance across cancers, especially clear cell renal cell carcinoma (ccRCC). Although clinical benefit exists, the immune-regulatory molecular signatures of CIK cells in cancers remain unclear. This work systematically identified CIK expansion-induced genes (CIK-EIGs) from transcriptomes, built a CIK-EIG-anchored framework across bulk and single-cell ccRCC datasets, and developed a risk stratification model for prognosis and phenotype definition. Integrative and experimental evidence highlighted TNFSF14 as a key modulator that enhances CIK effector function.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cytokine-induced-killer-cik-cells-associated-transcriptome-signature-reveals-the-potential-immunomodulatory-role-of-tnfsf14-in-clear-cell-renal-cell-carcinoma/353007/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cytokine-induced-killer-cik-cells-associated-transcriptome-signature-reveals-the-potential-immunomodulatory-role-of-tnfsf14-in-clear-cell-renal-cell-carcinoma/353007.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study on CIK cells in ccRCC?","Question",{"text":112,"@type":113},"To identify molecular signatures linked to the immune-regulatory role of cytokine-induced killer (CIK) cells in clear cell renal cell carcinoma and to build a transcriptome-based prognostic framework.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CIK expansion-induced genes (CIK-EIGs) defined?",{"text":117,"@type":113},"CIK-EIGs were derived from transcriptomic differences during ex vivo CIK generation, specifically comparing Day 14 mature CIK cells versus Day 0 PBMC.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does TNFSF14 play in the CIK-EIG-associated immune landscape?",{"text":121,"@type":113},"TNFSF14 is highlighted as a key functional modulator, strongly associated with cytotoxic immune signaling and cancer-immunity cycle activity, and functional assays confirm it enhances CIK-mediated tumor killing and effector responses in ccRCC cell lines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353007,1791139360,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Cancer Immunology, Immunotherapy (2026) 75:167  \n[https://doi.org/10.1007/s00262-026-04422-y](https://doi.org/10.1007/s00262-026-04422-y)  \nCytokine‑induced killer (CIK) Cells‑associated transcriptome signature reveals the potential immunomodulatory role of TNFSF14 in clear cell renal cell carcinoma  \nYinhao Chen1 · Linli Chen1 · Xinyue Qin2 · Yutao Li1 · Di Wu3 · Maria Fitria Setiawan1 · Veronika Lukacs‑Kornek4 · Manuel Ritter5 · Amit Sharma1 · Ingo G. H. Schmidt‑Wolf1  \nReceived: 21 January 2026 / Accepted: 7 May 2026 © The Author(s) 2026  \nAbstract  \nAmong adoptive immune cell therapies, cytokine-induced killer cell (CIK) therapy has demonstrated clear therapeutic relevance in multiple cancers, particularly clear cell renal cell carcinoma (ccRCC). Despite being clinically successful, the molecular signatures associated with the immune-regulatory role of these CIK cells in cancers remain elusive. Considering this, we systematically identified CIK expansion-induced genes (CIK-EIGs) from their transcriptome profiles and curated the CIK-EIG-anchored transcriptome framework across bulk and single-cell ccRCC datasets. Using comprehensive bioinformatics analysis, we next developed the CIK-EIG-anchored risk stratification (CIKRRS), which enabled reliable prediction of patient prognosis, correlated with the clinical-pathological course, and defined an immunologically inflamed but clinically unfavorable phenotype. Of interest, the integrative analyses highlighted TNFSF14 as one of the key functional modulators within the CIK-EIG-associated immune landscape, showing a strong association with cytotoxic immune signaling and cancerimmunity cycle activity. Subsequently, the functional assays verified that TNFSF14 significantly enhanced CIK-mediated tumor cell killing, degranulation, and cytokine production in ccRCC cell lines, confirming its role in enhancing CIK effector function. Taken together, our findings present a CIK-EIG-anchored transcriptomic and prognostic framework and highlight the potential relevance of TNFSF14 for further optimization of CIK-based immunotherapy in ccRCC patients.  \nKeywords Clear cell renal cell carcinoma · Cytokine-induced killer cell · Risk stratification · Machine learning · Immunotherapy  \nIntroduction  \nYinhao Chen, Linli Chen, and Xinyue Qin have contributed equally to this work.  \n* Amit Sharma [Amit.Sharma@ukbonn.de](Amit.Sharma@ukbonn.de)  \n* Ingo G. H. Schmidt-Wolf [ingo.schmidt-wolf@ukbonn.de](ingo.schmidt-wolf@ukbonn.de)  \n1 Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany  \n2 Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China  \nClear cell renal cell carcinoma (ccRCC) stands out from other kidney cancers due to its aggressive nature and tendency to metastasize, leading to a poor prognosis and high mortality [1] . ccRCC is notably resistant to conventional treatment modalities, including radiotherapy and  \n3 Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Nantong University, Nantong 226001, China  \n4 Institute of Molecular Medicine and Experimental Immunology, University Hospital of the Rheinische Friedrich-Wilhelms-University, 53127 Bonn, Germany  \n5 Department of Urology and Paediatric Urology, University Hospital Bonn, Bonn, Germany  \nchemotherapy [2] . As our knowledge of the molecular pathology of ccRCC expands, new targeted therapies and immunotherapies are being developed, showing considerable promise in improving outcomes for patients with advanced disease [3] . Moreover, the tumor microenvironment significantly influences ccRCC development and its response to therapy. Integrating relevant stromal and immune biomarkers may yield effective predictive and prognostic features, thereby informing the management of current therapeutic strategies and guiding future drug development [4] .  \nCytokine","cbCaivrfOwhV4Zq8","https://ap.wps.com/l/cbCaivrfOwhV4Zq8","pdf",13418501,18,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main goal of this study on CIK cells in ccRCC?\",\"answer\":\"To identify molecular signatures linked to the immune-regulatory role of cytokine-induced killer (CIK) cells in clear cell renal cell carcinoma and to build a transcriptome-based prognostic framework.\"},{\"question\":\"How were CIK expansion-induced genes (CIK-EIGs) defined?\",\"answer\":\"CIK-EIGs were derived from transcriptomic differences during ex vivo CIK generation, specifically comparing Day 14 mature CIK cells versus Day 0 PBMC.\"},{\"question\":\"What role does TNFSF14 play in the CIK-EIG-associated immune landscape?\",\"answer\":\"TNFSF14 is highlighted as a key functional modulator, strongly associated with cytotoxic immune signaling and cancer-immunity cycle activity, and functional assays confirm it enhances CIK-mediated tumor killing and effector responses in ccRCC cell lines.\"}]","Cytokine-induced killer (CIK) Cells-associated transcriptome signature reveals the potential immunomodulatory role of TNFSF14 in clear cell renal cell carcinoma | PDF",1790102544,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e1691fac0f653dfffe574a5529241c1b.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/471d28043da80e3bcfaf985413c1a55b.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cbd8ce23c57927313dba2e1c12b141d.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae79f8e185fbb8e1f3fdbd1f936dba02.webp",980,1301]